All Resources
Paper Summary
Immune-cell Functional Profiling Sheds Light on the Pathogenesis of Severe COVID-19

In a paper published in Immunity, researchers P. Szabo et al. used our Functional Proteomics to indicate that promoting lung-localized immune responses could be a viable alternative vaccination strategy for individuals, such as the immunocompromised or elderly, who are unable to develop effective systemic antibody responses.

What's Inside

In this Paper Summary we discuss:

The mechanisms behind pathogenic immune responses 
A better understanding leads to more effective therapeutic strategies
An airway-specific cell signature 
Airway immune cells work to create a pro-inflammatory environment
A Deeper Look

More about this Paper Summary

As of April 2021, COVID-19 has resulted in over two million deaths worldwide.

Immune response dysfunction has been implicated in severe COVID-19. However, the precise nature of these pathogenic systemic immune responses remains unclear.

In this study, published in Immunity, researchers used high-dimensional phenotypic, transcriptomic, and functional profiling techniques to identify key disease drivers in patients with severe COVID-19.

The study found evidence for myeloid cell-driven lung inflammation in severe COVID-19 and revealed potential therapeutic targets for reducing lung damage by inhibiting airway-specific inflammatory processes.

Download this Paper Summary to see the full findings!

Get the Paper Summary